Clinical Textbook of Addictive Disorders 3rd ed - R. Frances, S. Miller, A. Mack (Guilford, 2005) WW

432 IV. SPECIAL POPULATIONSto retention of HIV positive patients in ambulatory psychiatric treatment. Poster presentedat the annual meeting of the American Psychiatric Association, Philadelphia.Kennedy, C. A., Skurnick, J., Wan, J. Y., Quattrone, G., Sheffet, A., Quinones, M., etal. (1993). Psychological distress, drug and alcohol use as correlates of condom usein HIV-serodiscordant heterosexual couples. AIDS, 7, 1493–1499.Klein, T. W., Newton, C., Snella, E., & Friedman, H. (2001). Marijuana, thecannabinoid system, and immunolmodulation. In R. Ader, D. L. Felten, & N.Cohen (Eds.), Psychoneuroimmunology (3rd ed., pp. 415–432). San Diego, CA:Academic Press.Klisz, D. K., & Parsons, O. A. (1977). Hypothesis testing in younger and older alcoholic.J Stud Alcohol, 38, 1718–1729.Knowlton, A. R., Hoover, D. R., Chung, S. E., Celentano, D. D., Vlahov, D., & Latkin,C. A. (2001). Access to medical care and service utilization among injection drugusers with HIV/AIDS. Drug Alcohol Depend, 64, 55–62.Kolson, D. L., Lavi, E., Gonzalez, M., & Scarano, F. (1998). The effects of humanimmuno deficiency virus in the central nervous system. Adv Virus Res, 50, 1–47.Koutsilieri, E., Scheller, C., Sopper, S., ter Meulen, V., & Riederer, P. (2002). Thepathogenesis of HIV-induced dementia. Mech Ageing Dev, 123, 1047–1053.Kresina, T. F., Flexner, C. W., Sinclair, J., Correia, M. A., Stapleton, J., Adeniyi-Jones,S., et al. (2002). Alcohol use and HIV pharmacotherapy. AIDS Res Hum Retroviruses,18, 757–770.Kwiatkowski, C., Booth, R. E., & Lloyd, L. A. (2000). The effects of offering free treatmentto street-recruited opioid injectors. Addiction, 95, 697–704.Lindberg, C. (1996). HIV and pregnancy: Information for service providers. New Brunswick,NJ: New Jersey Women and AIDS Network.Ling, W., Charvuvastra, C., Collins, J. F., Batki, S., Brown, L. S., Kintaudi, P., et al.(1998). Buprenorphine maintenance treatment of opiate dependence: A multicenter,randomized clinical trial. Addiction, 93, 475–486.Ling, W., Compton, P., Rawson, R., & Wesson, D. (1996). Neuropsychiatry of alcoholand drug abuse. In B. Fogel, R. Schiffer, & S. Rao (Eds.), Neuropsychiatry (pp. 679–722). Baltimore: Williams & Wilkins.Lipton, S. A., & Gendelman, H. E. (1995). Seminars in medicine of the Beth IsraelHospital, Boston: Dementia associated with the acquired immunodeficiency syndrome.N Engl J Med, 332, 934–940.Lucas, G. M., Gebo, K. A., Chaisson, R. E., & Moore, R. D. (2002). Longitudinalassessment of the effects of drug and alcohol abuse on HIV-1 treatment outcomesin an urban clinic. AIDS, 16, 767–774.Lunn, S., Skydsbjerg, M., Schulsinger, H., Parnas, J., Pedersen, J., & Mathiesen, L.(1991). A preliminary report on the neuropsychologic sequelae of human immunodeficiencyvirus. Arch Gen Psychiatry, 48, 139–142.Lurie, P., & Drucker, E. (1997). An opportunity lost: HIV infections associated withlack of a national needle-exchange programme in the USA. Lancet, 349, 604–608.MacGregor, R. (1988). Alcohol and drugs as co-factors for AIDS. Adv Alcohol SubstAbuse, 7, 47–51.Mayne, T. J., Vittinghoff, E., Chesney, M. A., Barrett, D. C., & Coates, T. J. (1996).